178 related articles for article (PubMed ID: 33975394)
41. [Technical advancement improves survival in patients with locally advanced non-small cell lung cancer (LA-NSCLC) receiving definitive radiotherapy].
Wang JB; Jiang W; Ji Z; Cao JZ; Liu LP; Men Y; Xu C; Wang XZ; Hui ZG; Liang J; Lyu JM; Zhou ZM; Xiao ZF; Feng QF; Chen DF; Zhang HX; Yin WB; Wang LH
Zhonghua Zhong Liu Za Zhi; 2016 Aug; 38(8):607-14. PubMed ID: 27531481
[TBL] [Abstract][Full Text] [Related]
42. Toxicity and outcome of intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy for oropharyngeal cancer: a matched-pair analysis.
Al-Mamgani A; Van Rooij P; Tans L; Teguh DN; Levendag PC
Technol Cancer Res Treat; 2013 Apr; 12(2):123-30. PubMed ID: 23098281
[TBL] [Abstract][Full Text] [Related]
43. A comparative analysis of quality of life after postoperative intensity-modulated radiotherapy or three-dimensional conformal radiotherapy for cervical cancer.
Mohanty SK; Chopra S; Mudaliar A; Kannan S; Mahantshetty U; Engineer R; Ghosh J; Bajpai J; Gupta S; Shrivastava S
Indian J Cancer; 2018; 55(4):327-335. PubMed ID: 30829265
[TBL] [Abstract][Full Text] [Related]
44. A comparison of clinical outcomes between three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer.
Shimizuguchi T; Nihei K; Okano T; Machitori Y; Ito K; Karasawa K
Int J Clin Oncol; 2017 Apr; 22(2):373-379. PubMed ID: 27778117
[TBL] [Abstract][Full Text] [Related]
45. Radiation medicine innovations for the new millenium.
Heron DE; Godette KD; Wynn RA; Arterbery VE; Streeter OA; Roach M; Simpson JR; Blough M; Thomas CR
J Natl Med Assoc; 2003 Jan; 95(1):55-63. PubMed ID: 12656450
[TBL] [Abstract][Full Text] [Related]
46. The early adoption of intensity-modulated radiotherapy and stereotactic body radiation treatment among older Medicare beneficiaries with prostate cancer.
Jacobs BL; Yabes JG; Lopa SH; Heron DE; Chang CH; Schroeck FR; Bekelman JE; Kahn JM; Nelson JB; Barnato AE
Cancer; 2017 Aug; 123(15):2945-2954. PubMed ID: 28301689
[TBL] [Abstract][Full Text] [Related]
47. Technological advancements and error rates in radiation therapy delivery.
Margalit DN; Chen YH; Catalano PJ; Heckman K; Vivenzio T; Nissen K; Wolfsberger LD; Cormack RA; Mauch P; Ng AK
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e673-9. PubMed ID: 21669503
[TBL] [Abstract][Full Text] [Related]
48. Combination of dose escalation with technological advances (intensity-modulated and image-guided radiotherapy) is not associated with increased morbidity for patients with prostate cancer.
Pinkawa M; Piroth MD; Holy R; Djukic V; Klotz J; Krenkel B; Eble MJ
Strahlenther Onkol; 2011 Aug; 187(8):479-84. PubMed ID: 21789739
[TBL] [Abstract][Full Text] [Related]
49. Utilization of Neoadjuvant Intensity-modulated Radiation Therapy for Rectal Cancer in the United States.
Cushman TR; Venigalla S; Brooks ED; Lin C; Verma V
Anticancer Res; 2018 May; 38(5):2923-2927. PubMed ID: 29715118
[TBL] [Abstract][Full Text] [Related]
50. Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis.
Foster CC; Sher DJ; Rusthoven CG; Verma V; Spiotto MT; Weichselbaum RR; Koshy M
Radiat Oncol; 2019 Jan; 14(1):18. PubMed ID: 30691492
[TBL] [Abstract][Full Text] [Related]
51. Technological evolution of radiation treatment: Implications for clinical applications.
Pacelli R; Caroprese M; Palma G; Oliviero C; Clemente S; Cella L; Conson M
Semin Oncol; 2019 Jun; 46(3):193-201. PubMed ID: 31395286
[TBL] [Abstract][Full Text] [Related]
52. Clinical Effectiveness of an Adaptive Treatment Planning Algorithm for Intensity Modulated Radiation Therapy Versus 3D Conformal Radiation Therapy for Node-Positive Breast Cancer Patients Undergoing Regional Nodal Irradiation/Postmastectomy Radiation Therapy.
Bazan JG; Healy E; Beyer S; Kuhn K; DiCostanzo D; Smith TL; Jhawar S; White JR
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1159-1171. PubMed ID: 32711036
[TBL] [Abstract][Full Text] [Related]
53. Recent Trends of Medical Expenses Associated with Radiation Therapy in Korea Based on HIRA Big Data.
Lee JE; Yang K; Ahn YC; Park W; Huh SJ
Cancer Res Treat; 2023 Jul; 55(3):758-765. PubMed ID: 36731463
[TBL] [Abstract][Full Text] [Related]
54. Comparison of three-dimensional conformal radiation therapy, intensity-modulated radiation therapy, and volumetric-modulated arc therapy in the treatment of cervical esophageal carcinoma.
Yang H; Feng C; Cai BN; Yang J; Liu HX; Ma L
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27629865
[TBL] [Abstract][Full Text] [Related]
55. Quality of Life: A Prospective Randomized Trial of Palliative Volumetric Arc Therapy Versus 3-Dimensional Conventional Radiation Therapy.
Wong P; Lambert L; Thanomsack P; Coulombe G; Lambert C; Charpentier AM; Barkati M; Fortin I; Lafontaine J; Roberge D
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1431-1439. PubMed ID: 33259935
[TBL] [Abstract][Full Text] [Related]
56. Propensity score-based comparison of survival and radiation pneumonitis after definitive chemoradiation for esophageal cancer: Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy.
Lan K; Zhu J; Zhang J; Zhou S; Yang Y; Feng Z; Zhang L; Wang S; Xi M
Radiother Oncol; 2020 Aug; 149():228-235. PubMed ID: 32474127
[TBL] [Abstract][Full Text] [Related]
57. Evaluating Intensity-Modulated Radiation Therapy in Locally Advanced Non-Small-Cell Lung Cancer: Results From the National Cancer Data Base.
Jegadeesh N; Liu Y; Gillespie T; Fernandez F; Ramalingam S; Mikell J; Lipscomb J; Curran WJ; Higgins KA
Clin Lung Cancer; 2016 Sep; 17(5):398-405. PubMed ID: 26936682
[TBL] [Abstract][Full Text] [Related]
58. Clinical outcomes for gastric cancer following adjuvant chemoradiation utilizing intensity modulated versus three-dimensional conformal radiotherapy.
Liu GF; Bair RJ; Bair E; Liauw SL; Koshy M
PLoS One; 2014; 9(1):e82642. PubMed ID: 24416146
[TBL] [Abstract][Full Text] [Related]
59. Intensity-modulated radiation therapy achieves better local control compared to three-dimensional conformal radiation therapy for T4-stage nasopharyngeal carcinoma.
Chen JL; Huang YS; Kuo SH; Hong RL; Ko JY; Lou PJ; Wang CW
Oncotarget; 2017 Feb; 8(8):14068-14077. PubMed ID: 27764778
[TBL] [Abstract][Full Text] [Related]
60. The Clinical Status of Radiation Therapy in Korea in 2009 and 2013.
Kang JK; Kim MS; Jang WI; Kim HJ; Cho CK; Yoo HJ; Seo YS; Paik EK; Cha YJ
Cancer Res Treat; 2016 Jul; 48(3):892-8. PubMed ID: 26693912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
